Investor Relations
home » Investor Relations » Investor Relations Home

Investor Relations Home

Corporate Profile

Inovio Pharmaceuticals (NYSE Amex: INO) is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines. A comprehensive description of Inovio, its product pipeline, and its leading More >>

 

Recent News
Investor Alerts
Feb 22, 2012
Inovio Researchers Successfully Demonstrate RNA Drug Delivery via Electroporation
Feb 21, 2012
Inovio's Scientific Advisory Board Chairman Elected as a Fellow by the American Association for the Advancement of Science
Feb 6, 2012
Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference
Stock Quote
Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Inovio Pharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.

 


Print Email RSS